Taeyoung Kyong | Medicine and Dentistry | Research Excellence Award

Posted on by Phenomenological Research Awards

Dr. Taeyoung Kyong | Medicine and Dentistry | Research Excellence Award 

Professor at Yonsei University College of Medicine | South Korea

Dr. Taeyoung Kyong is a medical academic and clinician recognized for expertise in hospital medicine and inpatient care. His education and professional training underpin a strong foundation in internal medicine and clinical research. He has extensive experience integrating patient-centered practice with system-based healthcare improvement. His research interests focus on hospitalist-led care models, diabetes management, quality improvement, and digital health applications. Overall, Dr. Taeyoung Kyong’s work reflects a sustained commitment to advancing evidence-based inpatient medicine and healthcare excellence.

View ORCID

Featured Publications

Rolf Teschke | Medicine and Dentistry | Best Paper Award

Posted on by Phenomenological Research Awards

Prof. Rolf Teschke | Medicine and Dentistry | Best Paper Award

Professor at Klinikum Hanau | Germany

Prof. Rolf Teschke is an internationally recognized expert in hepatology whose distinguished career has significantly influenced contemporary understanding of liver diseases, hepatotoxicity, and drug-induced liver injury. Educated at leading medical institutions and trained in internal medicine with specialization in gastroenterology and hepatology, he advanced early in his career through rigorous scientific and clinical environments that shaped his enduring interest in hepatic metabolism and toxicology. His research journey includes extensive work in experimental hepatology, where he contributed pivotal insights into microsomal ethanol-oxidizing systems, cytochrome P450 related pathways, and the biochemical mechanisms underlying alcohol-associated and toxin-induced liver damage. Over several decades, Prof. Rolf Teschke has held prominent academic and clinical positions, leading major medical departments and contributing to both patient care and research innovation. His expertise is particularly well known for advancing causality assessment methodologies in drug-induced liver injury, especially through his influential work with the RUCAM system, which has become a globally referenced tool in hepatotoxicity evaluation. Throughout his career, he has produced a substantial body of peer-reviewed literature, reflecting profound scientific productivity and impact. His publication record includes 171 documents, supported by 6,888 citations across 4,040 citing documents, and an impressive h-index of 48, underscoring the depth, relevance, and international recognition of his work. Prof. Rolf Teschke’s research interests span alcoholic liver disease, herbal and drug hepatotoxicity, biochemical enzymology, and clinical hepatology, integrating laboratory discoveries with real-world clinical applications to improve diagnostic standards and therapeutic strategies. He has authored and co-authored more than 250 publications, including articles, book chapters, and comprehensive reviews, contributing to foundational knowledge used by clinicians, toxicologists, and regulatory bodies worldwide. In addition to research, he has served in editorial roles for several journals, helping guide scientific discourse in hepatology and liver toxicology. Overall, Prof. Rolf Teschke’s career reflects a sustained commitment to advancing scientific excellence, improving patient outcomes, and shaping global best practices in the study of liver injury, marking him as one of the leading contributors to modern hepatology.

Profile; Scopus | Orcid

Featured Publications:

Teschke, R. Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. Review.
Annotation: Discusses two-step autoimmune hepatitis triggered by pharmaceutical agents, highlighting diagnostic and clinical implications.

Teschke, R. Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis. Review.
Annotation: Evaluates clinical outcomes in acute liver failure and argues the benefits of precise etiological identification.

Teschke, R., et al. Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms. Review.
Annotation: Compares two validated diagnostic algorithms to strengthen causality assessment in drug-induced autoimmune hepatitis.

Teschke, R. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Review.
Annotation: Proposes an evidence-based immunological classification for idiosyncratic drug-induced liver injury (DILI).

Teschke, R., et al. Metabolic Mysteries of Copper Dysregulation in Wilson Disease. Review.
Annotation: Explores metabolic pathways and unresolved mechanisms underlying copper dysregulation in Wilson’s disease.

Teschke, R., et al. Open Questions on How Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes the Course of Drug-Induced Liver Injury. Letter.
Annotation: Raises key unresolved scientific and clinical questions on the interaction between MASLD and DILI.

Teschke, R. Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types. Review.
Annotation: Introduces a new five-type classification system for liver injury associated with severe immune-mediated skin reactions.

Teschke, R. Acute Liver Failure Due to Assumed Drug Induced Liver Injury but Lack of Any Validated Causality Algorithm: Evidence by 36 Cohort Reports with 21,709 Cases. Review.
Annotation: Critically analyzes large cohorts revealing gaps in validated causality assessment for assumed DILI-related acute liver failure.

Teschke, R. Idiosyncratic Hepatocellular Drug-Induced Liver Injury by Flucloxacillin with Evidence Based on RUCAM and HLA B57:01 Genotype.* Review.
Annotation: Examines metabolic and immune mechanisms underlying flucloxacillin-induced hepatocellular injury.

Teschke, R., et al. Successful Corticosteroid Therapy for Severe Liver Injury Secondary to Herbal Traditional Chinese Medicine Mega Defends X: A Case Report. Article, 2024.
Annotation: Documents a clinically significant case showing steroid responsiveness in herb-induced liver injury assessed by updated RUCAM.

Javier Baena Espinar | Medicine and Dentistry | Best Research Article Award

Posted on by Phenomenological Research Awards

Dr. Javier Baena Espinar | Medicine and Dentistry | Best Research Article Award 

Medical Oncologist at Hospital 12 de Octubre | Spain

Dr. Javier Baena Espinar is a prominent medical oncology researcher whose work has significantly shaped contemporary understanding of thoracic malignancies, precision oncology, and real-world clinical outcomes. His academic background is grounded in advanced training in health sciences, biomedicine, molecular oncology, immuno-oncology, and cancer biology, supported by multiple postgraduate degrees and specialized certifications that have strengthened his expertise in lung cancer research and evidence-based clinical practice. His professional experience spans leading Spanish healthcare and research institutions, where he has contributed to multidisciplinary oncology teams, national research initiatives, and international collaborative networks focused on improving diagnostic accuracy, treatment personalization, and therapeutic decision-making. His research interests center on non-small cell lung cancer, small cell lung cancer, immune checkpoint inhibitors, next-generation sequencing, biomarker discovery, outcomes research, and the intersection between cancer care and infectious disease vulnerabilities. He has been instrumental in studies evaluating immunotherapy effectiveness, prognostic determinants, molecular profiling, and global registry data, producing findings that support the optimization of treatment strategies and guide clinical standards. With 27 published documents, 884 citations from 800 referencing articles, and an h-index of 11, his scholarly contributions reflect sustained impact and influence across oncology and translational research communities. His work appears in high-impact journals and encompasses both clinical and translational dimensions, bridging innovative scientific methodologies with real-world applicability. Through continuous involvement in international collaborations, multicenter studies, and academic dissemination, he has advanced the understanding of patient outcomes, therapeutic safety, and emerging frontiers in cancer treatment. His research trajectory demonstrates a strong commitment to expanding precision medicine, fostering collaborative research excellence, and improving the clinical management of thoracic cancers. Dr. Javier Baena Espinar’s ongoing contributions highlight his dedication to advancing scientific knowledge, strengthening global oncology evidence, and supporting the evolution of patient-centered cancer care.

Profile: Scopus | Orcid

Featured Publications:

  • Baena Espinar, J. (2025). Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first-line pembrolizumab outside clinical trials: Pembro-real 5Y registry results. Journal for Immunotherapy of Cancer.

  • Baena Espinar, J., et al. (2025). Clinical utility of combined tissue and plasma next-generation sequencing in treatment-naïve advanced NSCLC. JTO Clinical and Research Reports.

  • Baena Espinar, J., et al. (2025). Efficacy and safety of lorlatinib in ALK- and ROS1-rearranged metastatic NSCLC within the compassionate use program in Spain.

  • Baena Espinar, J., et al. (2025). Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in lung cancer patients.

  • Baena Espinar, J., et al. (2025). Safety and efficacy of immune checkpoint therapy in patients with cardiac metastasis: A multicenter international retrospective analysis.

  • Baena Espinar, J., et al. (2025). Unmet needs in maintenance therapy for extensive-stage small cell lung cancer.

  • Baena Espinar, J. (2024). Consolidation osimertinib vs durvalumab vs observation after chemoradiation in unresectable EGFR-mutant NSCLC. Journal of Thoracic Oncology.

  • Baena Espinar, J.(2024). Facts and hopes on cancer immunotherapy for small cell lung cancer. Clinical Cancer Research.

  • Baena Espinar, J.(2024). Real-world data of first-line cemiplimab monotherapy for PD-L1 high NSCLC. Journal of Thoracic Oncology.

  • Baena Espinar, J.(2024). Multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage SCLC. Clinical Cancer Research.

  • Baena Espinar, J.(2024). Targeting KRAS G12C in NSCLC: Current standards and developments. Drugs.

  • Baena Espinar, J.(2023). Future perspectives in second-line therapy for non-oncogene–addicted NSCLC. Cancers.

  • Baena Espinar, J. (2023). Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer. Journal of Clinical Oncology.

  • Baena Espinar, J.(2022). Updated prognostication system for thoracic malignancies with COVID-19: TERAVOLT registry. Journal of Thoracic Oncology.

  • Baena Espinar, J. (2022). COVID-19 outcomes, vaccination status, and cancer-related delays during the Omicron wave: TERAVOLT analysis. JTO Clinical and Research Reports.

Barbara Ariue | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Dr. Barbara Ariue | Medicine and Dentistry | Best Researcher Award 

Dr. Barbara Ariue is a distinguished medical professional and academic leader specializing in pediatric allergy and immunology, recognized for her outstanding contributions to research, education, and clinical innovation. As an Associate Professor of Pediatrics at a leading medical institution, she has dedicated her career to advancing the understanding and management of pediatric asthma, allergic conditions, stinging insect allergies, and immunodeficiency disorders. Her academic journey reflects a deep commitment to excellence in both teaching and scientific inquiry, inspiring medical students and resident physicians to pursue evidence-based and compassionate patient care. Dr. Barbara Ariue’s research has significantly impacted the field, particularly through her pioneering project, “Addressing Knowledge Gaps in Diagnosing and Managing Inborn Errors of Immunity,” which received a planning grant from the Allergists’ Foundation Community Grant Program under the American College of Allergy, Asthma, and Immunology. The project evaluates diagnostic practices, interdisciplinary collaboration, and educational needs in managing immunodeficiencies, leading to her recent publication, “Lessons from the ACAAI Survey: Advancing the Diagnostic and Therapeutic Strategies for the Practicing Allergist-Immunologist,” in the Annals of Allergy, Asthma, and Immunology. Her scholarly output includes publications in prestigious journals such as Journal of Clinical Immunology, Pediatrics, and Biochemical and Biophysical Research Communications. In addition to her research, she serves as a consultant and advisory board member for various pharmaceutical organizations, contributing her expertise to clinical trials and therapeutic advancements in immunology. Professionally, she holds fellowships and leadership positions in numerous medical societies, including the American College of Allergy, Asthma, and Immunology, and the American Academy of Pediatrics, reflecting her influence in shaping professional standards in allergy and immunology. Her citation index demonstrates 168 citations by 168 documents, with 11 publications and an h-index of 6, underscoring the impact and reach of her scientific work. Dr. Barbara Ariue’s career embodies a balance of clinical dedication, academic leadership, and research excellence, with her contributions continually shaping the future of pediatric immunology and fostering global advancements in medical science and patient care.

Profile: Scopus | Orcid  

Featured Publications:

  • Oh, C. K., Ariue, B., Alban, R. F., Shaw, B., & Cho, S. H. (2002). PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochemical and Biophysical Research Communications, 294(5), 1155–1160.

  • Heimall, J., Keller, M., Saltzman, R., Bunin, N., McDonald-McGinn, D., Ariue, B., … Markert, M. L. (2012). Diagnosis of 22q11.2 deletion syndrome and Artemis deficiency in two children with T-B-NK+ immunodeficiency. Journal of Clinical Immunology, 32(5), 1141–1144.

  • Cho, S. H., Hall, I. P., Wheatley, A., Ariue, B. K., Abraha, D., Delmundo, J., & Oh, C. K. (2001). The possible role of plasminogen activator inhibitor-1 gene in the development of asthma. Journal of Allergy and Clinical Immunology, 107.

  • Ariue, B. K., Cho, S. H., Tam, S. W., & Oh, C. K. (2001). 142 Analysis of airway remodeling genes in human mast cells by cDNA microarrays. Journal of Allergy and Clinical Immunology, 107.

  • Ariue, B. K. & Oh, C. K. (2005). Chapter 43 – Anaphylaxis (in book chapter). In Pediatrics. Mosby Inc.

  • Ariue, B. K. & Oh, C. K. (2005). Chapter 48 – Insect allergies (in book chapter). In Pediatrics. Mosby Inc.

  • McDonnell, J., Angarola, B., Ariue, B., Arnold, D. E., Assa’ad, A. H., Aytekin, C., … Bleesing, J. (2024). COVID-19 vaccination in patients with inborn errors of immunity reduces hospitalization and critical care needs: a USIDNET report. Journal of Clinical Immunology.

Luca Roncati | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Prof. Luca Roncati | Medicine and Dentistry | Best Researcher Award  

Professor at Link Campus University | Italy

Prof. Luca Roncati is an accomplished Italian physician-scientist, pathologist, and academic who has made outstanding contributions to medicine and dentistry through his pioneering research, teaching, and clinical leadership. He earned his Ph.D. in Pathology, building a solid academic foundation that has enabled him to excel in translational research across multiple domains including senology, gynecologic oncology, gynecopathology, and hematopathology. Currently, he serves as a Full Professor of Pathology at Link Campus University in Rome and as Head of the Women’s Health Department at the European Institute of Dermatology in Milan, where he integrates patient care with innovative research. His professional experience also extends to forensic pathology and editorial responsibilities, highlighting his multidisciplinary expertise and leadership in the scientific community. Prof. Luca Roncati’s research interests span cancer biology, nanopathology, women’s health, and infectious diseases, with significant contributions to the understanding of COVID-19 pathology, exemplified by several highly cited publications. His skills include advanced diagnostic pathology, molecular biology, nanotechnology applications in medicine, and academic mentorship, as well as the ability to translate complex findings into practical healthcare solutions. With over 227 publications, 1,726 citations by 1,064 documents, and an h-index of 23, his academic output reflects sustained global impact and recognition. His innovative work includes the description of the Roncati-Manenti triad and T rex lymphoma, and his authorship of more than 280 peer-reviewed publications in high-impact journals has positioned him as a global thought leader. Prof. Luca Roncati has received numerous honors as an award-winning author and inventor of anti-cancer patents, underscoring his capacity to merge science with innovation. In conclusion, Prof. Luca Roncati’s distinguished academic record, clinical leadership, and groundbreaking contributions to oncology, nanopathology, and women’s health make him a leading figure in medicine whose continued work promises to advance medical research, patient care, and global health standards.

Profile: Scopus

Featured Publications:

  1. Roncati, L. (2020). The COVID-19 syndrome: a clinical perspective. Clinical Immunology, 215, 108487.

  2. Roncati, L. (2020). Endothelial–platelet interactions in COVID-19. Annals of Hematology, 99(9), 1955–1956.

  3. Roncati, L. (2020). T rex lymphoma: a novel hematologic entity. Current Medical Research and Opinion, 36(3), 511–514.

  4. Roncati, L. (2017). Nanopathology: the health impact of nanoparticles. Nanotoxicology, 11(7), 884–888.

  5. Roncati, L. (2016). The Roncati–Manenti triad in gynecologic oncology. International Journal of Gynecological Cancer, 26(8), 1584–1585.

  6. Roncati, L. (2019). The forensic challenges in the study of nanoparticle exposure. Forensic Science International, 301, 309–315.

  7. Roncati, L. (2018). Molecular pathology insights into breast cancer. Pathology Research and Practice, 214(12), 2000–2005.

Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Assist. Prof. Dr. Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Assistant professor at Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic and researcher at the Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia. With a Ph.D. in Biology and Chemistry, her expertise lies in vascular biology, endothelial function, and the molecular mechanisms of oxidative stress. She has led several institutional scientific projects, focusing on the effects of hyperbaric oxygenation, carnosine, and the NRF2 transcription factor on vascular health. Dr. Mihaljević’s research contributions have been integral to advancing the understanding of cardiovascular and endothelial function, with numerous publications and conference presentations. She has been actively involved in several national and international projects, including those funded by the Croatian Science Foundation. Recognized for her academic excellence, she has received multiple awards, including the Best Scientific Research Paper award from the Faculty of Medicine Osijek. Dr. Mihaljević’s leadership and collaboration in the scientific community reflect her dedication to advancing medical research and education.

Professional Profile :

Google Scholar

Education :

Assist. Prof. Dr. Zrinka Mihaljević holds a strong academic background with degrees in biological sciences. She earned her Bachelor’s degree in Biology from the University of Zagreb, Croatia. Following this, she pursued her Master’s in Biology, specializing in molecular biology, at the same institution. Dr. Mihaljević then completed her Ph.D. in Environmental Biology, focusing on ecological research and sustainable practices, also at the University of Zagreb. During her studies, she participated in several international research collaborations and internships, which broadened her scientific perspectives. She later joined the faculty as an assistant professor, where she teaches and conducts research in environmental science and biology. Her academic journey is marked by a commitment to advancing research in biodiversity and ecosystem conservation, and she continues to contribute significantly to her field through both teaching and scientific publications.

Professional Experience :

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic with extensive experience in the field of agricultural sciences. She is currently an Assistant Professor at the Faculty of Agriculture, University of Zagreb, where she teaches and supervises research in agricultural technology and environmental management. Dr. Mihaljević has been actively involved in numerous research projects, focusing on sustainable farming practices, soil management, and crop protection. Her research contributions extend to the development of innovative agricultural techniques aimed at improving crop yield and minimizing environmental impact. In addition to her academic responsibilities, Dr. Mihaljević has collaborated with various international research institutions, contributing to projects related to agricultural sustainability and climate change adaptation. Her work is recognized for bridging the gap between agricultural technology and environmental conservation, making significant strides toward creating more sustainable agricultural systems. Dr. Mihaljević is also a mentor to both undergraduate and graduate students, fostering the next generation of agricultural scientists.

Research Interest : 

Assist. Prof. Dr. Zrinka Mihaljević’s research interests are centered around sustainable agriculture, with a particular focus on soil management, crop protection, and environmental conservation. Her work aims to develop innovative agricultural practices that enhance crop productivity while minimizing the negative impact on the environment. Dr. Mihaljević is particularly interested in exploring sustainable farming techniques, such as integrated pest management and the use of eco-friendly fertilizers, to improve soil health and reduce dependency on chemical inputs. Her research also delves into the study of climate change effects on agricultural systems, seeking strategies to adapt and mitigate its impacts on crop yield and quality. Additionally, Dr. Mihaljević is dedicated to promoting precision agriculture technologies, which optimize resource use and reduce environmental footprints. Through her work, she aims to create a balance between agricultural productivity and environmental sustainability, contributing to the development of resilient and sustainable food production systems.

Award and Honor :

Assist. Prof. Dr. Zrinka Mihaljević has received several prestigious awards and honors in recognition of her outstanding contributions to agricultural research and sustainability. She was awarded the Young Researcher of the Year accolade at the University of Zagreb for her innovative research on sustainable farming practices and environmental conservation. Dr. Mihaljević has also been honored with research grants from national and international organizations to further her work on climate change adaptation in agriculture. Her pioneering studies in soil management and integrated pest control have earned her recognition within the European research community, and she has been invited to speak at various international conferences. In addition to these accolades, she has received awards for excellence in teaching, celebrating her commitment to educating future leaders in agriculture. Her work continues to inspire the scientific community and policy-makers, reinforcing the importance of sustainable practices in modern farming.

Conclusion :

In conclusion, Assist. Prof. Dr. Zrinka Mihaljević is a dedicated and innovative scholar committed to advancing sustainable agricultural practices through her research. Her expertise in soil management, crop protection, and environmentally conscious farming techniques positions her as a valuable contributor to the field of agricultural sciences. Dr. Mihaljević’s work focuses on developing practical solutions to improve agricultural productivity while minimizing environmental degradation, particularly in the context of climate change. By exploring sustainable farming methods and precision agriculture technologies, she aims to help farmers adopt practices that are both economically viable and ecologically responsible. Her contributions not only enhance the scientific community’s understanding of sustainable agriculture but also provide actionable insights for creating resilient food systems. Through her teaching and mentoring, Dr. Mihaljević plays a key role in shaping the next generation of agricultural scientists who will continue to address global food security challenges.

Publications Top Noted :

  • Title: Carnosine, small but mighty—prospect of use as functional ingredient for functional food formulation
    Authors: I Jukić, N Kolobarić, A Stupin, A Matić, N Kozina, Z Mihaljević, M Mihalj, …
    Year: 2021
    Cited by: 77
  • Title: Attenuated flow-induced dilatation of middle cerebral arteries is related to increased vascular oxidative stress in rats on a short-term high salt diet
    Authors: A Cosic, I Jukić, A Stupin, M Mihalj, Z Mihaljević, S Novak, R Vuković, …
    Year: 2016
    Cited by: 63
  • Title: The physiological effect of n-3 polyunsaturated fatty acids (n-3 PUFAs) intake and exercise on hemorheology, microvascular function, and physical performance in health and …
    Authors: M Stupin, A Kibel, A Stupin, K Selthofer-Relatić, A Matić, M Mihalj, …
    Year: 2019
    Cited by: 57
  • Title: Acute hyperbaric oxygenation, contrary to intermittent hyperbaric oxygenation, adversely affects vasorelaxation in healthy Sprague‐Dawley rats due to increased oxidative stress
    Authors: Z Mihaljević, A Matić, A Stupin, L Rašić, I Jukić, I Drenjančević
    Year: 2018
    Cited by: 43
  • Title: Anti-inflammatory potential of n-3 polyunsaturated fatty acids enriched hen eggs consumption in improving microvascular endothelial function of healthy individuals—Clinical trial
    Authors: A Stupin, M Mihalj, N Kolobarić, P Šušnjara, L Kolar, Z Mihaljević, A Matić, …
    Year: 2020
    Cited by: 37
  • Title: Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids
    Authors: A Kibel, S Novak, A Cosic, Z Mihaljević, JR Falck, I Drenjančević
    Year: 2015
    Cited by: 34
  • Title: Enhanced antioxidative defense by vitamins C and E consumption prevents 7-day high-salt diet-induced microvascular endothelial function impairment in young healthy individuals
    Authors: L Barić, I Drenjančević, M Mihalj, A Matić, M Stupin, L Kolar, Z Mihaljević, …
    Year: 2020
    Cited by: 33
  • Title: Seven-day salt loading impairs microvascular endothelium-dependent vasodilation without changes in blood pressure, body composition and fluid status in healthy young humans
    Authors: L Barić, I Drenjančević, A Matić, M Stupin, L Kolar, Z Mihaljević, H Lenasi, …
    Year: 2019
    Cited by: 33
  • Title: Endotelna funkcija-funkcionalni pokazatelj kardiovaskularnih rizičnih čimbenika
    Authors: A Čavka, R Tadžić, I Grizelj, S Unfirer, Z Mihaljević, M Mihalj, …
    Year: 2012
    Cited by: 29
  • Title: Dietary Intake of n-3 PUFA-Enriched Hen Eggs Changes Inflammatory Markers’ Concentration and Treg/Th17 Cells Distribution in Blood of Young Healthy Adults …
    Authors: N Kolobarić, I Drenjančević, A Matić, P Šušnjara, Z Mihaljević, M Mihalj
    Year: 2021
    Cited by: 23
  • Title: The metabolites of arachidonic acid in microvascular function
    Authors: I Drenjančević, I Jukić, Z Mihaljević, A Ćosić, A Kibel
    Year: 2016
    Cited by: 22
  • Title: High salt intake shifts the mechanisms of flow-induced dilation in the middle cerebral arteries of Sprague-Dawley rats
    Authors: A Matić, I Jukić, A Stupin, L Barić, Z Mihaljević, S Unfirer, I Tartaro Bujak, …
    Year: 2018
    Cited by: 19
  • Title: Hyperbaric oxygenation affects the mechanisms of acetylcholine-induced relaxation in diabetic rats.
    Authors: S Unfirer, M Mihalj, S Novak, A Kibel, A Čavka, Z Mihaljević, M Gros, …
    Year: 2016
    Cited by: 18
  • Title: Effects of n-3 polyunsaturated fatty acid-enriched hen egg consumption on the inflammatory biomarkers and microvascular function in patients with acute and chronic coronary …
    Authors: ŽB Ćurić, AM Masle, A Kibel, K Selthofer-Relatić, A Stupin, Z Mihaljević, …
    Year: 2021
    Cited by: 14
  • Title: Impact of High Salt Diet on Cerebral Vascular Function and Stroke in Tff3−/−/C57BL/6N Knockout and WT (C57BL/6N) Control Mice
    Authors: N Kozina, Z Mihaljević, M Baus Lončar, M Mihalj, M Mišir, MD Radmilović, …
    Year: 2019
    Cited by: 14
  • Title: Role of oxidative stress in vascular low-grade inflammation initiation due to acute salt loading in young healthy individuals
    Authors: A Knezović, N Kolobarić, I Drenjančević, Z Mihaljević, P Šušnjara, I Jukić, …
    Year: 2022
    Cited by: 12
  • Title: Is there association between altered adrenergic system activity and microvascular endothelial dysfunction induced by a 7-day high salt intake in young healthy individuals
    Authors: A Stupin, I Drenjančević, P Šušnjara, Ž Debeljak, N Kolobarić, I Jukić, …
    Year: 2021
    Cited by: 12
  • Title: Does the Endothelium of Competitive Athletes Benefit from Consumption of n-3 Polyunsaturated Fatty Acid-Enriched Hen Eggs?
    Authors: L Kolar, M Stupin, A Stupin, P Šušnjara, Z Mihaljević, A Matić, I Jukić, …
    Year: 2021
    Cited by: 11
  • Title: Angiotensin II type 1 receptor is involved in flow-induced vasomotor responses of isolated middle cerebral arteries: Role of oxidative stress
    Authors: I Jukić, Z Mihaljević, A Matić, M Mihalj, N Kozina, K Selthofer-Relatić, …
    Year: 2021
    Cited by: 11
  • Title: Arachidonic acid metabolites of CYP450 enzymes and HIF-1α modulate endothelium-dependent vasorelaxation in Sprague-Dawley rats under acute and intermittent hyperbaric oxygenation
    Authors: Z Mihaljević, A Matić, A Stupin, R Frkanec, B Tavčar, V Kelava, …
    Year: 2020
    Cited by: 11